Related Experiment Videos

Clinical Genetics, II. Huntington's disease: from the gene to pathophysiology

¹Maryland Psychiatric Research Center, Baltimore 21228, USA.

The American Journal of Psychiatry

|August 1, 1997

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits.

Proceedings of the National Academy of Sciences of the United States of America·2007

Maintenance of susceptibility to neurodegeneration following intrastriatal injections of quinolinic acid in a new transgenic mouse model of Huntington's disease.

Experimental neurology·2002

Mice transgenic for exon 1 of the Huntington's disease gene display reduced striatal sensitivity to neurotoxicity induced by dopamine and 6-hydroxydopamine.

The European journal of neuroscience·2001

Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2001

Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis.

Proceedings of the National Academy of Sciences of the United States of America·2001

Early and progressive accumulation of reactive microglia in the Huntington disease brain.

Journal of neuropathology and experimental neurology·2001

See all related articles